vs
Side-by-side financial comparison of American Healthcare REIT, Inc. (AHR) and JBT Marel Corp (JBTM). Click either name above to swap in a different company.
JBT Marel Corp is the larger business by last-quarter revenue ($1.0B vs $564.0M, roughly 1.8× American Healthcare REIT, Inc.). JBT Marel Corp runs the higher net margin — 5.3% vs 1.9%, a 3.4% gap on every dollar of revenue. On growth, JBT Marel Corp posted the faster year-over-year revenue change (115.6% vs 13.5%). Over the past eight quarters, JBT Marel Corp's revenue compounded faster (60.3% CAGR vs 11.7%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
JBT Marel Corporation, formerly known as JBT Corporation, or John Bean Technologies Corporation, is a food processing machinery and automated vehicle company. The company was incorporated in 2008 when FMC Technologies divested its non-energy businesses. The company is based in Chicago, Illinois and traces its history back to a company founded in 1884 by John Bean, an orchardist in Los Gatos, California.
AHR vs JBTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $564.0M | $1.0B |
| Net Profit | $10.8M | $53.1M |
| Gross Margin | 14.8% | 34.5% |
| Operating Margin | 19.8% | 7.2% |
| Net Margin | 1.9% | 5.3% |
| Revenue YoY | 13.5% | 115.6% |
| Net Profit YoY | 133.9% | 858.6% |
| EPS (diluted) | $0.07 | $1.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $564.0M | $1.0B | ||
| Q3 25 | $532.1M | $1.0B | ||
| Q2 25 | $501.3M | $934.8M | ||
| Q1 25 | $497.2M | $854.1M | ||
| Q4 24 | $496.8M | $467.6M | ||
| Q3 24 | $476.8M | $453.8M | ||
| Q2 24 | $458.0M | $402.3M | ||
| Q1 24 | $452.1M | $392.3M |
| Q4 25 | $10.8M | $53.1M | ||
| Q3 25 | $55.9M | $66.0M | ||
| Q2 25 | $9.9M | $3.4M | ||
| Q1 25 | $-6.8M | $-173.0M | ||
| Q4 24 | $-31.8M | $-7.0M | ||
| Q3 24 | $-4.1M | $38.9M | ||
| Q2 24 | $2.0M | $30.7M | ||
| Q1 24 | $-3.9M | $22.8M |
| Q4 25 | 14.8% | 34.5% | ||
| Q3 25 | 14.6% | 35.9% | ||
| Q2 25 | 15.0% | 35.8% | ||
| Q1 25 | 13.0% | 34.2% | ||
| Q4 24 | 13.3% | 38.4% | ||
| Q3 24 | 12.5% | 36.1% | ||
| Q2 24 | 12.1% | 35.6% | ||
| Q1 24 | 10.7% | 35.8% |
| Q4 25 | 19.8% | 7.2% | ||
| Q3 25 | 19.9% | 10.2% | ||
| Q2 25 | 20.6% | 5.2% | ||
| Q1 25 | 19.0% | -3.9% | ||
| Q4 24 | 20.0% | 3.4% | ||
| Q3 24 | 19.6% | 10.3% | ||
| Q2 24 | 19.4% | 6.7% | ||
| Q1 24 | 18.2% | 7.4% |
| Q4 25 | 1.9% | 5.3% | ||
| Q3 25 | 10.5% | 6.6% | ||
| Q2 25 | 2.0% | 0.4% | ||
| Q1 25 | -1.4% | -20.3% | ||
| Q4 24 | -6.4% | -1.5% | ||
| Q3 24 | -0.9% | 8.6% | ||
| Q2 24 | 0.4% | 7.6% | ||
| Q1 24 | -0.9% | 5.8% |
| Q4 25 | $0.07 | $1.04 | ||
| Q3 25 | $0.33 | $1.26 | ||
| Q2 25 | $0.06 | $0.07 | ||
| Q1 25 | $-0.04 | $-3.35 | ||
| Q4 24 | $-0.23 | $-0.22 | ||
| Q3 24 | $-0.03 | $1.21 | ||
| Q2 24 | $0.01 | $0.95 | ||
| Q1 24 | $-0.04 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $114.8M | $167.9M |
| Total DebtLower is stronger | — | $1.5B |
| Stockholders' EquityBook value | $3.3B | $4.5B |
| Total Assets | $5.4B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.33× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.8M | $167.9M | ||
| Q3 25 | $147.4M | — | ||
| Q2 25 | $133.5M | — | ||
| Q1 25 | $86.1M | — | ||
| Q4 24 | $76.7M | $1.2B | ||
| Q3 24 | $67.8M | — | ||
| Q2 24 | $52.1M | — | ||
| Q1 24 | $77.0M | — |
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $648.3M | ||
| Q2 24 | — | $647.7M | ||
| Q1 24 | — | $647.0M |
| Q4 25 | $3.3B | $4.5B | ||
| Q3 25 | $2.7B | $4.4B | ||
| Q2 25 | $2.4B | $4.4B | ||
| Q1 25 | $2.3B | $4.1B | ||
| Q4 24 | $2.3B | $1.5B | ||
| Q3 24 | $2.2B | $1.6B | ||
| Q2 24 | $1.9B | $1.5B | ||
| Q1 24 | $2.0B | $1.5B |
| Q4 25 | $5.4B | $8.2B | ||
| Q3 25 | $4.8B | $8.2B | ||
| Q2 25 | $4.5B | $8.3B | ||
| Q1 25 | $4.5B | $8.0B | ||
| Q4 24 | $4.5B | $3.4B | ||
| Q3 24 | $4.7B | $2.8B | ||
| Q2 24 | $4.6B | $2.7B | ||
| Q1 24 | $4.7B | $2.7B |
| Q4 25 | — | 0.33× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 0.35× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 0.81× | ||
| Q3 24 | — | 0.41× | ||
| Q2 24 | — | 0.43× | ||
| Q1 24 | — | 0.43× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $55.2M | $117.4M |
| Free Cash FlowOCF − Capex | — | $83.5M |
| FCF MarginFCF / Revenue | — | 8.3% |
| Capex IntensityCapex / Revenue | — | 3.4% |
| Cash ConversionOCF / Net Profit | 5.12× | 2.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $238.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $55.2M | $117.4M | ||
| Q3 25 | $107.2M | $87.7M | ||
| Q2 25 | $71.5M | $102.2M | ||
| Q1 25 | $60.6M | $34.4M | ||
| Q4 24 | $59.5M | $128.7M | ||
| Q3 24 | $63.1M | $71.9M | ||
| Q2 24 | $59.4M | $21.6M | ||
| Q1 24 | $-6.0M | $10.4M |
| Q4 25 | — | $83.5M | ||
| Q3 25 | — | $56.5M | ||
| Q2 25 | — | $83.7M | ||
| Q1 25 | — | $14.4M | ||
| Q4 24 | — | $118.7M | ||
| Q3 24 | — | $65.0M | ||
| Q2 24 | — | $11.1M | ||
| Q1 24 | — | $-100.0K |
| Q4 25 | — | 8.3% | ||
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | 9.0% | ||
| Q1 25 | — | 1.7% | ||
| Q4 24 | — | 25.4% | ||
| Q3 24 | — | 14.3% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | -0.0% |
| Q4 25 | — | 3.4% | ||
| Q3 25 | — | 3.1% | ||
| Q2 25 | — | 2.0% | ||
| Q1 25 | — | 2.3% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 2.6% | ||
| Q1 24 | — | 2.7% |
| Q4 25 | 5.12× | 2.21× | ||
| Q3 25 | 1.92× | 1.33× | ||
| Q2 25 | 7.21× | 30.06× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.85× | ||
| Q2 24 | 30.02× | 0.70× | ||
| Q1 24 | — | 0.46× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AHR
| Integrated Senior Health Campuses | $467.0M | 83% |
| SHOP | $97.0M | 17% |
JBTM
Segment breakdown not available.
